Predictive Technology Group, Inc. announced the appointment of Charles Andres, J.D., Ph.D., RAC, HBX CORe, to its Scientific Advisory Board. As an attorney at Wilson Sonsini Goodrich & Rosati, Mr. Andres leads the life sciences group in that firm’s Washington DC office. He represents a broad range of companies, including those at the forefront of cellular therapy, regenerative medicine, diagnostics, and immuno-oncology.